Skip to main content

August 2013 Vol 6, No 6 Special Issue

Lung Cancer, Oncology

Current Treatment of Advanced NSCLC Requires Testing for Driver Mutations

Lung Cancer, Oncology

Afatinib Doubles Progression-Free Survival Compared with Chemotherapy in Patients with Lung Cancer

Lung Cancer, Oncology

Dabrafenib Shows Promising Results in Patients with Stage IV NSCLC

Mammography Screening Rates Enhanced by Copay Elimination

Strategies to Overcome the Challenges of Personalized Medicine

Two Genetic Tests Can Prevent Overtreatment of Early Prostate Cancer

Pazopanib: First Positive Maintenance Trial in Ovarian Cancer

Causes of Hospital Readmissions of Patients with Cancer

Two Surveys Confirm Drug Shortages Are a Persistent Problem, Increasing Costs

Caroline Helwick

Poor Adherence to Oral Cancer Drugs a Growing Concern

Page 2 of 4
Results 11 - 20 of 34